Missulawin Jonathan 4

What Happened
Jonathan Missulawin, Chief Financial Officer of PolyPid Ltd. (PYPD), was granted a derivative award on May 11, 2026: options covering 49,000 shares with an exercise price of $4.46 per share, reported value $218,540. This was a grant/award transaction (code A) — not a market purchase or sale — and no shares were exercised or sold as part of this filing.

Key Details

• Transaction date: May 11, 2026; Filing date: July 17, 2026 (filed more than two months after the transaction).
• Award: 49,000 stock options at $4.46 per share; total reported amount $218,540.
• Vesting: Options vest quarterly beginning May 11, 2026 and continuing through May 11, 2030 (footnote).
• Shares owned after transaction: not specified in the filing.
• Transaction type: Derivative grant (A). No immediate exercise or sale reported.

Context
This was a compensation-related option grant subject to multi-year quarterly vesting, meaning the award vests over time rather than representing an immediate change in tradable shares. Because the filing date is well after the transaction date, the report appears late relative to the typical two-business-day Form 4 reporting window; late filings can reduce the timeliness of insider disclosure but do not by themselves indicate wrongdoing.